From: A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)
CPIS
Group A
Group B
A/B#
≤ 6
24 (75.0%)
18 (55.0%)
0.185
> 6
8 (25.0%)
14 (45.0%)